In the T2DM model, the expression of protein kinase B (Akt, gene name: Akt1) is inhibited, which affects the subsequent phosphorylation process, leading to insufficient Akt activation to carry sufficient signalling forward [45]. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.